Frontier Medicines

Frontier Medicines is a clinical-stage biopharmaceutical company pioneering the discovery and development of small-molecule covalent drugs against disease-causing proteins long considered undruggable. Its proprietary Frontier Platform pairs chemoproteomics with artificial intelligence and machine learning and a proprietary Druggability Atlas that maps thousands of novel covalent binding opportunities across the human proteome. Lead precision oncology candidates include FMC-376 (KRAS G12C), FMC-220 (a p53 Y220C reactivator), and FMC-242 (PI3Kalpha-RAS). Founded in 2018 with offices in Boston, Massachusetts and South San Francisco, California, the company is backed by DCVC and other life-science investors. Frontier Medicines was added to the API Evangelist network as a DCVC portfolio company; it publishes no public API or developer surface, so this profile captures company identity only.

Frontier Medicines is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Drug Discovery, Oncology, and Precision Medicine.

Frontier Medicines’ developer surface includes engineering blog, support, and 7 more developer resources.

🌐 Visit website 📡 Source on GitHub

13.0/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiopharmaceuticalDrug DiscoveryOncologyPrecision MedicineCovalent ChemistryChemoproteomicsArtificial IntelligenceLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 13.0/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/frontier-medicines: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 6

The organization behind the API

Website

About

Blog

Careers

LinkedIn

Twitter

Twitter

Source (apis.yml)

aid: frontier-medicines
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/frontier-medicines.png
name: Frontier Medicines
description: Frontier Medicines is a clinical-stage biopharmaceutical company pioneering the discovery and development of
  small-molecule covalent drugs against disease-causing proteins long considered undruggable. Its proprietary Frontier Platform
  pairs chemoproteomics with artificial intelligence and machine learning and a proprietary Druggability Atlas that maps thousands
  of novel covalent binding opportunities across the human proteome. Lead precision oncology candidates include FMC-376 (KRAS
  G12C), FMC-220 (a p53 Y220C reactivator), and FMC-242 (PI3Kalpha-RAS). Founded in 2018 with offices in Boston, Massachusetts
  and South San Francisco, California, the company is backed by DCVC and other life-science investors. Frontier Medicines
  was added to the API Evangelist network as a DCVC portfolio company; it publishes no public API or developer surface, so
  this profile captures company identity only.
url: https://raw.githubusercontent.com/api-evangelist/frontier-medicines/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- dcvc
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biopharmaceutical
- Drug Discovery
- Oncology
- Precision Medicine
- Covalent Chemistry
- Chemoproteomics
- Artificial Intelligence
- Life Sciences
apis: []
common:
- type: Website
  url: https://www.frontiermeds.com/
- type: About
  url: https://www.frontiermeds.com/about/
- type: Blog
  url: https://www.frontiermeds.com/newsroom/
- type: Careers
  url: https://www.frontiermeds.com/careers/
- type: Support
  url: https://www.frontiermeds.com/contact/
- type: PrivacyPolicy
  url: https://www.frontiermeds.com/privacy-policy/
- type: TermsOfService
  url: https://www.frontiermeds.com/terms-of-use/
- type: LinkedIn
  url: https://www.linkedin.com/company/frontier-medicines/
- type: Twitter
  url: https://x.com/frontiermeds
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence